Molecular Diagnostics Market 2021 | Statistics, Competition Strategies, Business Analysis, Global Size and Future Investment Analysis with Covid-19 Impact, Tendencies and Forecast to 2030

In a recent published report, Kenneth Research has updated the market report for Molecular Diagnostics Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Molecular Diagnostics Market products.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10085364

According to a report by the World Health Organization (WHO), the total health spending is growing with an annual average rate of 6% in the low- and middle-income nations, and close to 4% in the high-income countries. Further, in the year 2016, the expenditure made on health reached close to 10% of the GDP of the world and crossed a value of USD 7 trillion.

Global Molecular Diagnostics Market (US-specific Market Assessment) – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024
Overview: Molecular diagnostics is the branch of clinical pathology or laboratory medicine that utilizes various molecular biology techniques to diagnose diseases, predict disease course, select treatments, and monitor the effectiveness of therapies. These tests are performed mainly to examine the existence of the disease in blood, tissue, or even in bones. The importance of nucleic acids and other cellular biomarkers in defining the vital cellular process has facilitated medical advancements in the diagnosis of various diseases. Early diagnosis of the disease is one of the key advantages of this technology. The capacity of molecular diagnostics to systematize molecular reactions for the enhancement of the clinical diagnosis has put healthcare in the front line. According to the estimation of the American Cancer Society, around 1,688,780 new cancer cases were diagnosed, and 600,920 people died due to cancer in 2017. According to the study by World Health Organization (WHO), approximately 14 million new cancer cases were diagnosed in 2017 and is expected to grow by about 70% over the next 2 decades. The outbreak of swine flu in Myanmar and India, in 2017, increased the demand for diagnosis in the Asia Pacific region. It is noticed that there is a considerable rise in the number of cases reported in 2017 when compared to 2016.

The market for molecular diagnostics is driven by increasing prevalence of infectious and other lifestyle diseases, increasing demand for non-invasive biomarker-based tests, growing adoption of point-of-care testing, and high growth of the market in emerging countries. Increasing number of mergers & acquisitions and growing significance of companion diagnostics are providing opportunities for the market growth. Low awareness about standardization, stringent regulatory approval process, and lack of skilled labors are hampering the market growth.

Market Analysis: The global molecular diagnostics market is estimated to witness a CAGR of 8.7% during the forecast period 2018–2024. The US occupied a dominant market share, i.e., 32% in 2017, and is expected to grow at a CAGR of 8.4% during the forecast period 2018–2024. The market is analyzed based on four segments – applications, technologies, end-users, and regions.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10085364

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder, followed by Europe, in the global molecular diagnostics market with the US contributing to significant market revenue. Increasing incidences of disease and organ transplantation in the US along with increasing funding by government & private players and increased adoption of personalized medicine in clinical practices are few of the factors driving the US molecular diagnostics market growth. Various countries in the Americas region are taking initiatives for the elimination of viral hepatitis, but the major challenge remains in the diagnosis of the disease. This is providing an opportunity for manufacturers to enhance their market presence. The Asia Pacific region is expected to witness the fastest growth rate due to the large patient pool, increasing awareness, and rising healthcare expenditure.

Technology Analysis: PCR occupied significant share in the global molecular diagnostics market in 2017. PCR is a gold standard technique for DNA amplification and is the primary technique conducted prior to any molecular diagnostic examination. Next-generation sequencing and microarray are expected to grow at the fastest rate during the forecast period. 

Application Analysis: Among various application areas, the infectious disease application occupied the largest share in 2017 and cancer application is expected to grow at the highest growth rate during the forecast period. A large number of patients suffering from hospital-associated infection, sexually transmitted infection (STI), hepatitis, respiratory infection, pathogen ID detection, and others is fostering the market growth. Increasing incidence of cancer globally makes it the fastest growing application segment during the forecast period.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10085364

Key Players: F. Hoffmann-La Roche, Hologic, Inc., Danaher Corporation, Abbott Laboratories, and Siemens Healthineers Inc. are the key players in the market. Becton Dickenson and Company, bioMerieux S.A., Bio-Rad Laboratories, Inc., Qiagen NV, Grifols, S.A, Thermo Fisher Scientific, Sysmex Corporation, and Myriad Genetics are few predominate & niche players.
Competitive Analysis: Polymerase Chain Reaction (PCR) occupied a significant share in the molecular diagnostics market. The emerging players are focusing on developing NGS and microarray technology to have the edge in the market. The increasing importance of molecular diagnostic tests has resulted in the launch of new tests and also increased acquisition, strategic partnership, and funding to develop new tests and technologies. For instance, in April 2018, NanoString Technologies, Inc. launched a Breast Cancer 360 (BC 360) research panel. In July 2017, MDxHealth SA announced the commercial launch of its AssureMDx for bladder cancer test in the US as a laboratory developed test. Illumina recently started a new company, named GRAIL, for liquid biopsy. It invested $100 million and raised another $900 million through public funding to develop new non-invasive tests for cancer diagnosis.

Benefits: The report provides complete details about the usage and adoption rate of molecular diagnostics in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives the complete information about the key business opportunities to key stakeholders to analyze before investing or expanding the business in this market.

Table of Content
1 INDUSTRY OUTLOOK
1.1 Industry overview
1.2 Total addressable market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Basic Steps of Molecular diagnostics
3.3 Segmented Addressable Market (SAM)
3.4 Major Trends in the Molecular Diagnostics Market
3.5 Related Markets
3.5.1 Liquid Biopsy
3.5.2 Point-of-Care diagnostics
3.5.3 Immunoassays
3.5.4 Clinical Chemistry
4 Market Outlook
4.1 Evolution iof Molecular Diagnostics
4.2 Market segmentation
4.3 PEST Analysis
4.4 Porter 5(Five) Forces
5 Market Characteristics
5.1 DRO – Global Molecular Diagnostics Market Dynamics
5.1.1 Drivers
5.1.1.1 Rising Prevalence of Infectious Disease
5.1.1.2 Growing Adoption of Point-of-care Testing
5.1.1.3 Increasing Demand for Biomarker-based Tests
5.1.1.4 High Growth of the Market in Emerging Countries
5.1.2 Opportunities
5.1.2.1 Growing Significance of Companion Diagnostics
5.1.2.2 Increase in Number of Mergers and Acquisitions
5.1.2.3 Increased Adoption of DNA Probe-based Diagnostics
5.1.3 Restraints
5.1.3.1 Stringent Regulatory Approvals
5.1.3.2 Lack of Skilled Labors
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Technology: Market Size and Analysis
6.1 Overview
6.2 PCR
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4 Microarray
6.5 Hybridization
6.6 DNA sequencing

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

James Bullock is a Research Expert with a demonstrated history of working in the professional training & coaching industry. Strong professional skilled in business strategy , Strategic Planning, Research Strategy, and Marketing. also have interest in new innovations and technology

Leave a Reply